BP p.l.c. (BP) BP p.l.c. engages in the energy business worldwide. It operates through Gas & Low Carbon Energy, Oil Production & Operations, Customers & Products, and Rosneft segments. It produces and trades in natural gas; offers biofuels; operates onshore and offshore wind power, and solar power generating facilities; Veritiv Corporation (VRTV) Veritiv Corporation operates […]
Read MoreNo matter how tired we get of hearing about COVID-19, there is no denying that ever since the virus found its way to American shores more than two years ago, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names […]
Read MorePermianville Royalty Trust (PVL) Permianville Royalty Trust operates as a statutory trust. It owns a net profits interest representing the right to receive 80% of the net profits from the sale of oil and natural gas production from properties located in the states of Texas, Louisiana, and New Mexico. BELLUS Health Inc. (BLU) BELLUS Health […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTIC $4.9300 0.1200 % 2.4900 Cti Biopharm Corp […]
Read MoreOvintiv Inc. (OVV) Ovintiv Inc., together with its subsidiaries, engages in the exploration, development, production, and marketing of natural gas, oil, and natural gas liquids. It operates through USA Operations, Canadian Operations, and Market Optimization segments. Amphastar Pharmaceuticals, Inc. (AMPH) Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, […]
Read More(Bloomberg) — Two biopharmaceutical companies enjoyed a meme-like day on Monday, surging at least twofold on promising results. Veru Inc. more than tripled intraday in its biggest jump ever with more than 293 million shares changing hands, by far a daily record. The gains come after a late-stage study of the drug developer’s experimental medicine […]
Read MoreFor most of the past two years, any examination of the Pharmaceutical industry has necessarily begun and ended with COVID-19 vaccines. Literally, of course, this isn’t true; diseases and viruses of all kinds don’t take a holiday during a pandemic, and so development of existing projects for any company in this industry hasn’t stopped, either. […]
Read MoreOver the last year, the pandemic has consistently defied attempts to look past its effects and global impact and to a still-hoped-for “return to normal.” Variants of the virus sparked multiple infection waves through 2021 that kept hospitalizations high and strained the health care system in general. As 2022 started, some of those effects appear […]
Read MoreNo matter how tired we get of hearing about COVID-19, there is no denying that ever since the virus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world worked nonstop […]
Read MoreIVERIC bio, Inc. (ISEE) IVERIC bio, Inc., a biopharmaceutical company, develops novel therapies to treat ophthalmic diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company is developing Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial. Cytokinetics, Incorporated (CYTK) Cytokinetics, Incorporated, a late-stage […]
Read MoreOver the course of my investing career, I have learned to rely on a lot of fundamental data to paint a picture about the underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share and price-to-earnings ratios, […]
Read MoreSynaptogenix, Inc. (SNPX) Synaptogenix, Inc. operates as a biopharmaceutical company. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer’s disease. Range Resources Corporation (RRC) Range Resources Corporation operates as an independent natural gas, natural gas liquids (NGLs), and oil company in the United States. The […]
Read MoreAs recently as last summer, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As new, even more contagious variants of the virus have emerged, however, it has become […]
Read MoreAs I’ve studied the market over the years, one of the intriguing contrasts comes in the way different analysis methods take in the “big picture” of the market. That includes the way that fundamental investors and analysts look at the market versus those that prefer to work on strictly technical terms. I like to work […]
Read MoreAbbVie Inc. (ABBV) AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet’s diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in […]
Read More